Therapeutic strategies in RET gene rearranged non-small cell lung cancer

Overview of attention for article published in Journal of Hematology & Oncology, March 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#15 of 1,258)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 32 news stories from 25 outlets.

Helsinn presents newly available data on vepafestinib at IASLC 2022 World Conference on Lung Cancer Lugano, Switzerland, August…

Helsinn presents newly available data on vepafestinib at IASLC 2022 World Conference on Lung Cancer Lugano, Switzerland, August…

Helsinn presents newly available data on vepafestinib at IASLC 2022 World Conference on Lung Cancer Lugano, Switzerland, August…

News provided by Helsinn Healthcare S.A. Aug 08, 2022, 4:07 AM ET Helsinn presents newly available data on vepafestinib at…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 28 additional news stories.